Table 3.
DerSimonian-Laird random-effects model analysis for MBL under different follow-ups
| Follow-up (months) | Studies*/implants (n) | MBL estimate (95% CI) (mm) | SE | p value | Heterogeneity |
|---|---|---|---|---|---|
| 2–6 | 9/333 | 0.948 (0.641, 1.256) | 0.157 | < 0.001 | τ2 = 0.196, p < 0.001, I2 = 91.941 |
| 12–15 | 15/697 | 0.632 (0.434, 0.830) | 0.101 | < 0.001 | τ2 = 0.130, p < 0.001, I2 = 93.299 |
| 18–24 | 5/183 | 1.021 (0.274, 1.769) | 0.381 | 0.007 | τ2 = 0.704, p < 0.001, I2 = 99.577 |
| 30–36 | 7/413 | 0.892 (0.429, 1.354) | 0.236 | < 0.001 | τ2 = 0.354, p < 0.001, I2 = 96.225 |
| 48 | 2/36 | 2.060 (1.885, 2.235) | 0.089 | < 0.001 | τ2 = 0.045, p = 0.048, I2 = 81.493 |
| 60 | 5/217 | 0.958 (0.705, 1.211) | 0.129 | < 0.001 | τ2 = 0.068, p < 0.001, I2 = 89.234 |
| 70–132 | 6/321 | 1.175 (0.876, 1.473) | 0.152 | < 0.001 | τ2 = 0.123, p < 0.001, I2 = 94.685 |
MBL, marginal bone loss; 95% CI, 95% confidence interval; SE, standard error
*When data on MBL for all implants in a study was not available (as a global mean value), then data on the mean value of the different sub-groups was entered. In these cases, each sub-group was considered one “study”